- CA$1.95bn
- CA$1.43bn
- CA$2.38bn
- 74
- 68
- 90
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 120 | 197 | 333 | 1,816 | 2,376 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 125 | 191 | 268 | 1,776 | 2,285 |
Operating Profit | -4.76 | 6.05 | 64.5 | 39.7 | 90.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 11.2 | 39.5 | 80.4 | 39.7 | 90.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.09 | 32.4 | 62.6 | 27.8 | 66.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 5.09 | 32.4 | 62.6 | 27.8 | 66.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5 | 32.4 | 62.6 | 27.8 | 66.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.046 | 0.924 | 1.5 | 0.676 | 1.4 |